Zobrazeno 1 - 7
of 7
pro vyhledávání: '"W. L. Schary"'
Autor:
I.L. Honigberg, Francis R. Pelsor, G. E. Francisco, W. L. Schary, Jeffrey A. Kotzan, Vinod P. Shah, James T. Stewart, W. J. Brown
Publikováno v:
Biopharmaceutics & Drug Disposition. 5:335-344
The purpose of the study was to examine the bioequivalence of five commercially available oral prednisone products. The in vivo study utilized 18 healthy males, each of whom was administered 20 mg of prednisone as a reference solution or as a tablet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e28c93f10c1fb9563affc7b4fbf49ee
https://doi.org/10.1002/bdd.2510050405
https://doi.org/10.1002/bdd.2510050405
Autor:
R. N. Fogoros, Charles C. Whitney, Denise L. Howrie, W. L. Schary, H. J. Pieniaszek, Randy P. Juhl, Lewis W. Dittert
Publikováno v:
European Journal of Clinical Pharmacology. 32:607-610
Moracizine (ethmozine) is a phenothiazine derivative with demonstrated antiarrhythmic activity. To characterize the pharmacokinetics and material balance relationships in humans, we have given 14C-moracizine X HCl as a single oral dose of 500 mg (50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff377e9085f8b29370d43d7d6f38aa1d
https://doi.org/10.1007/bf02455996
https://doi.org/10.1007/bf02455996
Publikováno v:
The Journal of pharmacy and pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfc406a9727d091df0eb6ffbce24345d
https://pubmed.ncbi.nlm.nih.gov/22648
https://pubmed.ncbi.nlm.nih.gov/22648
Publikováno v:
Clinical therapeutics. 7(2)
This study was designed to assess the bioequivalence of intramuscular molindone hydrochloride and marketed oral molindone. Ten schizophrenic patients (mean age, 30.2 years) received oral molindone in single daily doses of 100 or 150 mg for four to ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2879264c004d141fe1f0149c9e1002c4
https://pubmed.ncbi.nlm.nih.gov/3986861
https://pubmed.ncbi.nlm.nih.gov/3986861
Publikováno v:
The Journal of clinical psychiatry. 45(9 Pt 2)
Healthy male volunteers (N = 24) participated in a four-way crossover study to compare the rate and extent of absorption of naltrexone after administration of 50 mg tablets as 50, 100, and 200 mg doses and a 10 mg/ml reference syrup. A high-performan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b8faa84af458765727a5b8d0be9f513
https://pubmed.ncbi.nlm.nih.gov/6469932
https://pubmed.ncbi.nlm.nih.gov/6469932
Publikováno v:
Research communications in chemical pathology and pharmacology. 10(4)
The effect of phenylbutazone on the disposition of warfarin was studied in a subject given warfarin daily for one month. During concomitant phenylbutazone administration, the total plasma warfarin concentration declined from 4.2 to 2.0 mg/L. In contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22e54f4ee66072a8f7c3dd963f921856
https://pubmed.ncbi.nlm.nih.gov/1153844
https://pubmed.ncbi.nlm.nih.gov/1153844
Publikováno v:
European journal of clinical pharmacology. 33(3)
The pharmacokinetics of intravenously, intramuscularly, and subcutaneously administered nalbuphine were studied in three parallel groups of 12 healthy volunteers each. The subjects received single doses of 10 mg and 20 mg of nalbuphine separated by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632935cfb9adcdfbcf2a25a22aaa3b90
https://pubmed.ncbi.nlm.nih.gov/3691617
https://pubmed.ncbi.nlm.nih.gov/3691617